---
figid: PMC2734392__nihms128736f3
figtitle: NAD biosynthetic pathways in yeast, invertebrates, and mammals
organisms:
- Saccharomyces cerevisiae
- Homo sapiens
pmcid: PMC2734392
filename: nihms128736f3.jpg
figlink: /pmc/articles/PMC2734392/figure/F3/
number: F3
caption: NAD biosynthetic pathways in yeast, invertebrates, and mammals. (A) The NAD
  biosynthetic pathways in the budding yeast Saccharomyces cerevisiae and invertebrates,
  such as C. elegans and Drosophila. PNC1, NPT1, NMA1 and NMA2, QNS1, and QPT1 are
  nicotinamidase, nicotinic acid phosphoribosyltransferase, nicotinic acid mononucleotide
  adenylyltransferase 1 and 2, NAD synthetase, and quinolinic acid phosphoribosyltransfease,
  respectively. Only SIR2 is shown as a representative NAD-dependent protein deacetylase.
  NIC, nicotinamide; NA, nicotinic acid; NaMN, nicotinic acid mononucleotide. B) The
  NAD biosynthetic pathways in mammals. The de novo pathway and the NAD biosynthetic
  pathway from nicotinic acid are evolutionarily conserved, while the NAD biosynthetic
  pathway from nicotinamide (red arrows) is vertebrate-specific and mediated by nicotinamide
  phosphoribosyltransferase (NAMPT). Nicotinamide is the main precursor for NAD biosynthesis
  in mammals. While multiple enzymes break NAD into nicotinamide and ADP-ribose, only
  SIRT1 is shown here. NMN, nicotinamide mononucleotide. C) The reaction catalyzed
  by NAMPT. PPi, inorganic pyrophosphate.
papertitle: Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in
  type 2 diabetes.
reftext: Shin-ichiro Imai, et al. Front Biosci. ;14:2983-2995.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7963681
figid_alias: PMC2734392__F3
figtype: Figure
organisms_ner:
- Saccharomyces cerevisiae S288C
redirect_from: /figures/PMC2734392__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2734392__nihms128736f3.html
  '@type': Dataset
  description: NAD biosynthetic pathways in yeast, invertebrates, and mammals. (A)
    The NAD biosynthetic pathways in the budding yeast Saccharomyces cerevisiae and
    invertebrates, such as C. elegans and Drosophila. PNC1, NPT1, NMA1 and NMA2, QNS1,
    and QPT1 are nicotinamidase, nicotinic acid phosphoribosyltransferase, nicotinic
    acid mononucleotide adenylyltransferase 1 and 2, NAD synthetase, and quinolinic
    acid phosphoribosyltransfease, respectively. Only SIR2 is shown as a representative
    NAD-dependent protein deacetylase. NIC, nicotinamide; NA, nicotinic acid; NaMN,
    nicotinic acid mononucleotide. B) The NAD biosynthetic pathways in mammals. The
    de novo pathway and the NAD biosynthetic pathway from nicotinic acid are evolutionarily
    conserved, while the NAD biosynthetic pathway from nicotinamide (red arrows) is
    vertebrate-specific and mediated by nicotinamide phosphoribosyltransferase (NAMPT).
    Nicotinamide is the main precursor for NAD biosynthesis in mammals. While multiple
    enzymes break NAD into nicotinamide and ADP-ribose, only SIRT1 is shown here.
    NMN, nicotinamide mononucleotide. C) The reaction catalyzed by NAMPT. PPi, inorganic
    pyrophosphate.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BNA6
  - NPT1
  - NMA2
  - NMA1
  - PNC1
  - SIR2
  - deamido-NAD
  - nicotinamide
  - nicotinic acid
  - pyrophosphate
  - Tryptophan
  - Quinolinic acid
  - O-acetyl-ADP-ribose
---
